Literature DB >> 23820810

Dialysis: Effect of cinacalcet on survival--the saga continues.

Hirotaka Komaba1, Masafumi Fukagawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23820810     DOI： 10.1038/nrneph.2013.130

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Discrepancies between meta-analyses and subsequent large randomized, controlled trials.

Authors:  J LeLorier; G Grégoire; A Benhaddad; J Lapierre; F Derderian
Journal:  N Engl J Med       Date:  1997-08-21       Impact factor: 91.245

2.  Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan.

Authors:  Hirotaka Komaba; Kensuke Moriwaki; Shunsuke Goto; Shunsuke Yamada; Masatomo Taniguchi; Takatoshi Kakuta; Isao Kamae; Masafumi Fukagawa
Journal:  Am J Kidney Dis       Date:  2012-03-24       Impact factor: 8.860

3.  Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

Authors:  Glenn M Chertow; Geoffrey A Block; Ricardo Correa-Rotter; Tilman B Drüeke; Jürgen Floege; William G Goodman; Charles A Herzog; Yumi Kubo; Gerard M London; Kenneth W Mahaffey; T Christian H Mix; Sharon M Moe; Marie-Louise Trotman; David C Wheeler; Patrick S Parfrey
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

4.  Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism.

Authors:  John Cunningham; Mark Danese; Kurt Olson; Preston Klassen; Glenn M Chertow
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

5.  The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis.

Authors:  Paolo Raggi; Glenn M Chertow; Pablo Urena Torres; Botond Csiky; Agostino Naso; Kaldun Nossuli; Moustafa Moustafa; William G Goodman; Nicole Lopez; Gerry Downey; Bastian Dehmel; Jürgen Floege
Journal:  Nephrol Dial Transplant       Date:  2010-12-08       Impact factor: 5.992

6.  Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients.

Authors:  Geoffrey A Block; David Zaun; Gerard Smits; Martha Persky; Stephanie Brillhart; Kimberly Nieman; Jiannong Liu; Wendy L St Peter
Journal:  Kidney Int       Date:  2010-06-16       Impact factor: 10.612

7.  Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism.

Authors:  Hirotaka Komaba; Shohei Nakanishi; Akira Fujimori; Motoko Tanaka; Jeongsoo Shin; Koji Shibuya; Masato Nishioka; Hirohito Hasegawa; Takeshi Kurosawa; Masafumi Fukagawa
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-26       Impact factor: 8.237

8.  Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.

Authors:  Geoffrey A Block; Kevin J Martin; Angel L M de Francisco; Stewart A Turner; Morrell M Avram; Michael G Suranyi; Gavril Hercz; John Cunningham; Ali K Abu-Alfa; Piergiorgio Messa; Daniel W Coyne; Francesco Locatelli; Raphael M Cohen; Pieter Evenepoel; Sharon M Moe; Albert Fournier; Johann Braun; Laura C McCary; Valter J Zani; Kurt A Olson; Tilman B Drüeke; William G Goodman
Journal:  N Engl J Med       Date:  2004-04-08       Impact factor: 91.245

9.  Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol.

Authors:  Ignacio Lopez; Escolastico Aguilera-Tejero; Francisco J Mendoza; Yolanda Almaden; Jose Perez; David Martin; Mariano Rodriguez
Journal:  J Am Soc Nephrol       Date:  2006-02-08       Impact factor: 10.121

Review 10.  Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.

Authors:  Suetonia C Palmer; Ionut Nistor; Jonathan C Craig; Fabio Pellegrini; Piergiorgio Messa; Marcello Tonelli; Adrian Covic; Giovanni F M Strippoli
Journal:  PLoS Med       Date:  2013-04-30       Impact factor: 11.069
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.